[Efficiency of cytoflavin in the treatment of somatoform disorders].  AIM
To study the efficacy of cytoflavin in patients with somatoform disorders (SD).  MATERIAL AND METHODS
The study included 60 patients with SD, aged from 27 to 43 years.
The efficacy was assessed by the results of psychological and neurophysiological examinations.  RESULTS AND CONCLUSION
The higher efficacy of cytoflavin (the improvement of patient's condition in 63,3% of cases) compared to that of ethylmethylhydroxypyridine succinate (56,7% of cases) was found.
Patient's state was more stable after treatment with cytoflavin.
